Narrow search
Showing 1 - 10 of 122
Cover Image
The impact of physician-level drug budgets on prescribing behavior
Blankart, Katharina; Koch, Taika; Kostev, Karel; … - In: The European journal of health economics : HEPAC ; … 19 (2018) 2, pp. 213-222
Persistent link: https://www.econbiz.de/10011946212
Cover Image
The diffusion of generics after patent expiry in Germany
Blankart, Katharina; Stargardt, Tom - In: The European journal of health economics : HEPAC ; … 17 (2016) 8, pp. 1027-1040
Persistent link: https://www.econbiz.de/10011660160
Cover Image
Hybrid risk adjustment for pharmaceutical benefits
García-Goñi, Manuel; Ibern, Pere; Inoriza, José María - In: The European journal of health economics : HEPAC ; … 10 (2009) 3, pp. 299-308
Persistent link: https://www.econbiz.de/10003857250
Cover Image
How removing prescription drugs from reimbursement lists increases the pharmaceutical expenditures for alternatives
Özden Gür Ali; Topaler, Başak - In: The European journal of health economics : HEPAC ; … 12 (2011) 6, pp. 553-562
Persistent link: https://www.econbiz.de/10009376933
Cover Image
Is it time to reconsider the role of patient co-payments for pharmaceuticals in Europe?
Drummond, Michael F.; Towse, Adrian - In: The European journal of health economics : HEPAC ; … 13 (2012) 1, pp. 1-5
Persistent link: https://www.econbiz.de/10009491176
Cover Image
Compulsory licensing and access to drugs
Stavropoulou, Charitini; Valletti, Tommaso M. - In: The European journal of health economics : HEPAC ; … 16 (2015) 1, pp. 83-94
Persistent link: https://www.econbiz.de/10011300285
Cover Image
Competitive pricing within pharmaceutical classes : evidence on ‘‘follow-on’’ drugs in Germany 1993 - 2008
Mueller, Michael T.; Frenzel, Alexander - In: The European journal of health economics : HEPAC ; … 16 (2015) 1, pp. 73-82
Persistent link: https://www.econbiz.de/10011300287
Cover Image
Endogenous technological change in medicine and its impact on healthcare costs : evidence from the pharmaceutical market in Taiwan
Hsieh, Chee-Ruey; Liu, Ya Ming; Chang, Chia-lin - In: The European journal of health economics : HEPAC ; … 14 (2013) 2, pp. 287-295
Persistent link: https://www.econbiz.de/10009719729
Cover Image
Impact of parallel trade on pharmaceutical firm's profits : rise or fall?
Guo, Shen; Hu, Bin; Zhong, Hai - In: The European journal of health economics : HEPAC ; … 14 (2013) 2, pp. 345-355
Persistent link: https://www.econbiz.de/10009720309
Cover Image
Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures? : editorial
Farfan-Portet, María-Isabel; Gerkens, Sophie; … - In: The European journal of health economics : HEPAC ; … 15 (2014) 3, pp. 223-228
Persistent link: https://www.econbiz.de/10010361510